To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene ZFC3H1TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
220 supporting clones for gene ZFC3H1 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
NM_144982.4   .a 1 to 7158 1 to 7158 exact RefSeq,   7158/7158
(100 %)
0 diff
(100 %id)
DB167969 kidney, tumor tissue .a 80 to 640 2 to 563   tiling clone, capped   562/562
(100 %)
1 diff
(99.9 %id)
CN303336 embryonic stem cells, DMSO-treated H9 cellline .a 91 to 706 3 to 619       617/619
(99 %)
6 diff
(99.1 %id)
BG481241 choriocarcinoma, placenta .a 111 to 760 1 to 650   available from MGC,   650/650
(100 %)
1 diff
(99.9 %id)
AL704524 human skeletal muscle .a 113 to 441 1 to 329       329/329
(100 %)
1 diff
(99.7 %id)
BX647709 human testis .a 121 to 7153 1 to 7033 A988V tiling clone, available from DKFZ, AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 7033/7033
(100 %)
5 diff
(100.0 %id)
BX471274   .a 121 to 505 1 to 385       385/385
(100 %)
2 diff
(99.5 %id)
AU252587 neuroblastoma .a 134 to 789 43 to 697       655/700
(93 %)
11 diff
(98.5 %id)
DA042496 bladder .a 135 to 706 2 to 577   capped   576/576
(100 %)
4 diff
(99.4 %id)
BC064336 Lymph, lymphoma .a 137 to 1556 18 to 1437   tiling clone, available from MGC,   1420/1420
(100 %)
3 diff
(99.8 %id)
BF796542 lymph, lymphoma, cell line .a 137 to 681 27 to 580   available from MGC,   554/580
(95 %)
6 diff
(99.0 %id)
AL710249 human skeletal muscle .a 138 to 492 1 to 355       355/355
(100 %)
2 diff
(99.5 %id)
CN303335 embryonic stem cells, DMSO-treated H9 cellline .a 139 to 747 1 to 608       608/610
(99 %)
2 diff
(99.7 %id)
BI518497 leukocyte .a 146 to 1004 1 to 864   available from MGC,   864/869
(99 %)
10 diff
(98.9 %id)
TI_44459037   .a 146 to 1004 32 to 895       864/900
(96 %)
12 diff
(98.7 %id)
BP362344 thalamus .a 150 to 729 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
BX645730   .a 151 to 657 1 to 507       507/507
(100 %)
1 diff
(99.9 %id)
AL710042 human skeletal muscle .a 173 to 452 1 to 280       280/280
(100 %)
5 diff
(98.3 %id)
BP396281 pancreatic islet .a 249 to 749 501 to 1       501/501
(100 %)
0 diff
(100 %id)
TI_154185403   .a 348 to 944 83 to 685       603/1016
(59 %)
22 diff
(97.9 %id)
CF147455 lymph .a 349 to 833 1 to 485       485/485
(100 %)
0 diff
(100 %id)
CV030139 mixed .a 360 to 932 1 to 573       573/573
(100 %)
0 diff
(100 %id)
TI_1948230641   .a 360 to 957 133 to 730   AAA   598/1215
(49 %)
1 diff
(100.0 %id)
AL704137 human skeletal muscle .a 622 to 1370 19 to 767       749/767
(97 %)
7 diff
(99.1 %id)
AI866623 brain, tumor, 5 pooled (see description) .a 914 to 1310 397 to 1       397/397
(100 %)
1 diff
(99.8 %id)
BF814735 colon_ins .a 976 to 1527 19 to 569       551/673
(81 %)
12 diff
(98.3 %id)
CD704329 normal nasopharynx .a 1083 to 1537 31 to 485       455/485
(93 %)
9 diff
(98.2 %id)
AI985513 Kidney .a 1180 to 1541 362 to 1       362/362
(100 %)
0 diff
(100 %id)
BX476059   .a 1327 to 1912 24 to 609       586/609
(96 %)
8 diff
(98.7 %id)
BX484213   .a 1594 to 2055 1 to 462       462/462
(100 %)
1 diff
(99.8 %id)
BX956573   .a 1692 to 2302 1 to 611       611/611
(100 %)
0 diff
(100 %id)
CN369645 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 1703 to 2425 1 to 723       723/723
(100 %)
2 diff
(99.8 %id)
CF272688   .a 1838 to 2118 281 to 1     Submitted on the opposite strand 281/281
(100 %)
0 diff
(100 %id)
BF327524 breast_normal .a 1979 to 2171 7 to 201       199/201
(99 %)
7 diff
(96.6 %id)
BF376636 testis_normal .a 1981 to 2171 1 to 196       203/196
(103 %)
9 diff
(95.5 %id)
CN369644 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 2376 to 2648 1 to 269       269/269
(100 %)
5 diff
(98.2 %id)
BX644267   .a 2380 to 2999 1 to 620       620/620
(100 %)
0 diff
(100 %id)
CX781059 human embryonic stem cells .a 2387 to 3231 1 to 845       845/845
(100 %)
0 diff
(100 %id)
CN369643 embryonic stem cells, cell lines H1, H7, andH9 .a 2492 to 3049 1 to 558       558/558
(100 %)
3 diff
(99.5 %id)
DR005967 Prostate .a 2502 to 2888 1 to 387       387/387
(100 %)
0 diff
(100 %id)
AK125035 thalamus .a 2547 to 7070 1 to 4525   tiling clone, available from FLJ,   4525/4525
(100 %)
3 diff
(100.0 %id)
DA400522 thalamus .a 2548 to 3102 2 to 556   capped   555/555
(100 %)
1 diff
(99.9 %id)
AW197148 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney .a 2628 to 3134 507 to 1       507/507
(100 %)
0 diff
(100 %id)
DB157057 thymus .a 2687 to 3267 2 to 582   capped   581/581
(100 %)
4 diff
(99.4 %id)
CD657221 Embryonic Stem cells .a 2720 to 3481 21 to 784       766/863
(88 %)
19 diff
(97.8 %id)
DA222886 brain .a 2961 to 3494 2 to 535   capped   534/534
(100 %)
1 diff
(99.9 %id)
CN430322 embryonic stem cells, cell lines H1, H7, andH9 .a 3126 to 3842 1 to 718       718/718
(100 %)
2 diff
(99.8 %id)
AI184530   .a 3180 to 3602 432 to 10   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 423/432
(97 %)
0 diff
(100 %id)
DA807023 brain .a 3307 to 3876 2 to 572   capped   571/571
(100 %)
1 diff
(99.9 %id)
DA799448 brain .a 3371 to 3909 2 to 540   capped   539/539
(100 %)
3 diff
(99.5 %id)
DB160960 thymus .a 3415 to 3986 2 to 574   capped   573/573
(100 %)
1 diff
(99.9 %id)
DA803056 brain .a 3605 to 4157 2 to 554   capped   553/553
(100 %)
0 diff
(100 %id)
BE646534 B-cell, chronic lymphotic leukemia .a 3640 to 4213 574 to 1       574/574
(100 %)
0 diff
(100 %id)
DB164194 thymus .a 3684 to 4253 2 to 572   capped   571/571
(100 %)
1 diff
(99.9 %id)
BE674845 B-cell, chronic lymphotic leukemia .a 3762 to 4213 452 to 1       452/452
(100 %)
0 diff
(100 %id)
AA115639 colon, tumor .a 3911 to 4488 1 to 580       580/580
(100 %)
16 diff
(97.3 %id)
DA120436 cerebellum .a 3928 to 4481 2 to 556   capped   555/555
(100 %)
1 diff
(99.9 %id)
DA120466 cerebellum .a 3928 to 4490 2 to 565   capped   564/564
(100 %)
1 diff
(99.9 %id)
AI890579 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .a 3990 to 4594 605 to 1       605/605
(100 %)
2 diff
(99.7 %id)
DA022698   .a 4070 to 4621 2 to 554   capped   553/553
(100 %)
1 diff
(99.9 %id)
DN995376 breast cancer, Mammary gland (cancer tissue) .a 4119 to 4686 1 to 568       568/568
(100 %)
4 diff
(99.3 %id)
BM828166 Ascites, stomach .a 4259 to 4751 1 to 493       493/493
(100 %)
0 diff
(100 %id)
DB165510 thymus .a 4299 to 4903 2 to 606   capped   605/605
(100 %)
0 diff
(100 %id)
DB145241 thymus .a 4309 to 4858 2 to 551   capped   550/550
(100 %)
0 diff
(100 %id)
AL045556 testis .a 4325 to 4833 1 to 525       524/525
(99 %)
15 diff
(97.2 %id)
DA882327   .a 4457 to 5004 2 to 549   capped   548/548
(100 %)
0 diff
(100 %id)
DA259356 caudate nucleus .a 4486 to 5046 2 to 562   capped   561/561
(100 %)
3 diff
(99.5 %id)
DB056716 testis .a 4588 to 5124 2 to 538   capped   537/537
(100 %)
1 diff
(99.9 %id)
EB360821 eye, lens .a 4621 to 5133 513 to 1       513/515
(99 %)
1 diff
(99.9 %id)
AA322549 brain, cerebellum .a 4662 to 4941 1 to 280       280/280
(100 %)
0 diff
(100 %id)
DA794591 brain .a 4776 to 5340 2 to 566   capped   565/565
(100 %)
1 diff
(99.9 %id)
DA985354 synovial membrane tissue from rheumatioidarthritis .a 4788 to 5348 2 to 562   capped   561/561
(100 %)
1 diff
(99.9 %id)
BE541200 cervix .a 4809 to 5473 1 to 668       668/874
(76 %)
20 diff
(97.8 %id)
DA746369   .a 4877 to 5443 2 to 569   capped   568/568
(100 %)
1 diff
(99.9 %id)
DA761387 tongue .a 4954 to 5486 2 to 534   capped   533/533
(100 %)
0 diff
(100 %id)
CN314792 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 4975 to 5614 13 to 652       640/652
(98 %)
9 diff
(98.7 %id)
DA022507   .a 5000 to 5571 2 to 573   capped   572/572
(100 %)
1 diff
(99.9 %id)
BQ718765 sympathetic trunk .a 5057 to 5506 12 to 463       452/911
(49 %)
9 diff
(99.1 %id)
AU124701   .a 5072 to 5795 2 to 755   capped   754/866
(87 %)
29 diff
(96.7 %id)
BX281504 adenocarcinoma, cell line, Liver .a 5289 to 5766 1 to 478       478/478
(100 %)
0 diff
(100 %id)
AV687100 hepatocellular carcinoma .a 5289 to 5886 1 to 591       591/632
(93 %)
9 diff
(98.6 %id)
AV689320 hepatocellular carcinoma .a 5289 to 5886 1 to 591       591/616
(95 %)
7 diff
(98.9 %id)
BG121390 adenocarcinoma, cell line, Liver .a 5289 to 5985 1 to 702       702/1030
(68 %)
17 diff
(98.4 %id)
DB243186 stomach, tumor tissue .a 5379 to 5956 2 to 579   capped   578/578
(100 %)
0 diff
(100 %id)
TI_44159238   .a 5517 to 6240 71 to 796   fully sequenced,   726/796
(91 %)
14 diff
(98.3 %id)
BI523669 pooled lung and spleen .a 5525 to 6240 1 to 716   fully sequenced,   716/716
(100 %)
11 diff
(98.5 %id)
R60365 whole brain .a 5594 to 5997 1 to 407     Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 407/489
(83 %)
11 diff
(97.8 %id)
H08097 whole brain .a 5594 to 5984 1 to 398     Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 398/478
(83 %)
9 diff
(98.2 %id)
BG013525 placenta_normal .a 5667 to 5911 245 to 2       244/247
(98 %)
9 diff
(96.4 %id)
BE896880 melanotic melanoma, skin .a 5803 to 6295 19 to 523       505/524
(96 %)
27 diff
(94.9 %id)
CN314791 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 6044 to 6688 1 to 648       648/648
(100 %)
5 diff
(99.3 %id)
CN314796 embryonic stem cells, DMSO-treated H9 cellline .a 6045 to 6348 1 to 304       304/304
(100 %)
0 diff
(100 %id)
AA121934 uterus .a 6092 to 6571 14 to 499       486/500
(97 %)
14 diff
(97.2 %id)
AA476680.
matches multiple genes
  .a 6168 to 6548 1 to 381     also hits gene FNDC4 381/381
(100 %)
0 diff
(100 %id)
BI524821 pooled lung and spleen .a 6209 to 7006 818 to 6   fully sequenced,   813/818
(99 %)
42 diff
(94.9 %id)
TI_44159239   .a 6209 to 7006 818 to 6   fully sequenced,   813/818
(99 %)
42 diff
(94.9 %id)
AA115640 colon, tumor .a 6478 to 7071 595 to 1       595/596
(99 %)
11 diff
(98.2 %id)
DB326865 brain .a 6517 to 7063 547 to 1       547/547
(100 %)
0 diff
(100 %id)
AU148506   .a 6536 to 7066 532 to 1       532/532
(100 %)
10 diff
(98.2 %id)
CX780980 human embryonic stem cells .a 6548 to 7072 550 to 26       525/550
(95 %)
0 diff
(100 %id)
H08098 whole brain .a 6645 to 7066 459 to 19   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 441/441
(100 %)
35 diff
(92.1 %id)
BX484214   .a 6646 to 7040 395 to 1       395/395
(100 %)
11 diff
(97.3 %id)
R60309 whole brain .a 6728 to 7063 359 to 22   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 338/340
(99 %)
5 diff
(98.6 %id)
DB312130 thalamus .a 6832 to 7070 240 to 1       240/240
(100 %)
2 diff
(99.2 %id)
AB011118 brain .b 1 to 7597 1 to 7597 exact tiling clone, available from KIAA,   7597/7597
(100 %)
2 diff
(100.0 %id)
BQ949578 sciatic nerve .b 5426 to 6017 1 to 603       603/1191
(50 %)
19 diff
(98.5 %id)
BQ890765 sciatic nerve .b 5859 to 6353 11 to 507   tiling clone,   497/933
(53 %)
19 diff
(98.0 %id)
FN108444 breast carcinoma .b 6175 to 6280 106 to 1     Submitted on the opposite strand 106/113
(93 %)
4 diff
(96.5 %id)
AA446797   .b 6438 to 6907 1 to 469   tiling clone,   469/469
(100 %)
1 diff
(99.8 %id)
TI_149314639   .b 6939 to 7810 942 to 84   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 859/966
(88 %)
21 diff
(97.9 %id)
CB321747 lung, Primary Lung Cystic Fibrosis EpithelialCells .b 7091 to 7810 738 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 720/720
(100 %)
2 diff
(99.8 %id)
AA432112   .b 7173 to 7605 436 to 4       433/436
(99 %)
0 diff
(100 %id)
AI276747 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 7248 to 7696 451 to 3       449/451
(99 %)
0 diff
(100 %id)
AI684790 pooled .b 7397 to 7813 417 to 1       417/417
(100 %)
6 diff
(98.6 %id)
BC015679 Placenta, choriocarcinoma .c 1 to 1481 1 to 1481 exact tiling clone, available from MGC, AAA   1481/1481
(100 %)
0 diff
(100 %id)
TI_1948076214   .c 243 to 543 134 to 434   fully sequenced,   301/434
(69 %)
5 diff
(98.9 %id)
TI_1948076574   .c 243 to 568 130 to 454   fully sequenced,   325/454
(71 %)
6 diff
(98.7 %id)
TI_1948076753   .c 243 to 543 121 to 421   fully sequenced,   301/421
(71 %)
5 diff
(98.9 %id)
TI_1948076396   .c 364 to 1324 1084 to 126       959/1275
(75 %)
28 diff
(97.9 %id)
TI_1948076215   .c 513 to 1324 929 to 126   fully sequenced,   804/929
(86 %)
2 diff
(99.8 %id)
TI_1948076754   .c 513 to 1324 940 to 125   fully sequenced,   816/940
(86 %)
1 diff
(99.9 %id)
TI_1948076575   .c 538 to 1324 912 to 127   fully sequenced,   786/912
(86 %)
1 diff
(99.9 %id)
BC073843 Blood, adult leukocytes .d 1 to 1768 1 to 1768 exact tiling clone, available from MGC, AAA   1768/1768
(100 %)
0 diff
(100 %id)
TI_1948230304   .d 215 to 843 135 to 766   fully sequenced,   632/766
(82 %)
10 diff
(98.7 %id)
TI_1948230474   .d 215 to 812 133 to 730       598/1162
(51 %)
6 diff
(99.5 %id)
TI_1948230805   .d 215 to 812 135 to 732       598/1235
(48 %)
6 diff
(99.6 %id)
TI_1948230305   .d 813 to 1254 573 to 132   fully sequenced,   442/573
(77 %)
0 diff
(100 %id)
TI_1948230475   .d 813 to 1254 571 to 130       442/1452
(30 %)
0 diff
(100 %id)
TI_1948230806   .d 813 to 1254 577 to 136       442/1493
(29 %)
0 diff
(100 %id)
CR747521 B-cell, chronic lymphotic leukemia .e 1 to 498 1 to 496   tiling clone,   496/496
(100 %)
1 diff
(99.8 %id)
BF516233   .e 96 to 632 550 to 14   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 537/550
(97 %)
1 diff
(99.9 %id)
AI066760   .e 120 to 632 515 to 3   tiling clone,   513/515
(99 %)
0 diff
(100 %id)
BI460552 testis .f 1 to 861 1 to 868 exact tiling clone,   868/891
(97 %)
29 diff
(96.8 %id)
BI769801 pooled lung and spleen .g 1 to 626 1 to 628   tiling clone,   628/774
(81 %)
8 diff
(99.0 %id)
TI_57179500   .g 2 to 626 32 to 658   AAA   627/793
(79 %)
9 diff
(98.9 %id)
W56506 heart .g 22 to 467 1 to 455   tiling clone,   453/464
(97 %)
15 diff
(96.8 %id)
DA828929 placenta .g 304 to 808 2 to 507   tiling clone, capped   506/509
(99 %)
4 diff
(99.3 %id)
CD106972 brain, Pituitary .g 1049 to 1881 1 to 841 S44F L45S R46* tiling clone,   841/857
(98 %)
10 diff
(98.9 %id)
W56777 heart .g 1889 to 2312 425 to 1   tiling clone,   425/430
(98 %)
1 diff
(99.8 %id)
DB373554 placenta .g 1966 to 2309 344 to 1   tiling clone,   344/344
(100 %)
5 diff
(98.6 %id)
BM152068 leukopheresis .h 1 to 382 1 to 381   tiling clone,   381/381
(100 %)
14 diff
(96.4 %id)
BX491218   .h 305 to 854 1 to 549   tiling clone,   549/549
(100 %)
3 diff
(99.5 %id)
CD675975 eye, lens .h 812 to 1458 1 to 647   tiling clone,   647/647
(100 %)
4 diff
(99.4 %id)
CN314793 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .h 1454 to 2204 11 to 760   tiling clone,   750/763
(98 %)
4 diff
(99.5 %id)
BE467631 carcinoid, lung .h 1514 to 2029 516 to 1       516/516
(100 %)
1 diff
(99.9 %id)
AA313646 Liver .h 1645 to 1904 1 to 260       260/260
(100 %)
0 diff
(100 %id)
AL079620 testis .h 1806 to 1959 1 to 153       153/153
(100 %)
6 diff
(96.1 %id)
BX952847   .i 1 to 280 4 to 283 R3X tiling clone,   283/283
(100 %)
2 diff
(99.3 %id)
AV708641 adrenal gland .j-u 1 to 360 14 to 373   tiling clone,   360/373
(96 %)
11 diff
(97.1 %id)
CK430779 eye, lacrimal gland .j-u 163 to 819 1 to 658 exact     658/658
(100 %)
3 diff
(99.6 %id)
AA320247 adipose tissue, white .j-u 300 to 545 1 to 246   tiling clone,   246/246
(100 %)
0 diff
(100 %id)
AI557287 Prostate .j-u 379 to 1038 685 to 24 exact tiling clone,   662/812
(81 %)
0 diff
(100 %id)
BG676919 skin, squamous cell carcinoma .j-u 804 to 1644 1 to 841       841/848
(99 %)
3 diff
(99.7 %id)
BF088283 head_neck .j-u 848 to 1095 1 to 246       246/247
(99 %)
7 diff
(97.2 %id)
CN314795 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .j-u 858 to 1516 9 to 667       659/667
(98 %)
6 diff
(99.2 %id)
CA430275 cell lines, Chondrosarcoma .j-u 926 to 1688 780 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 762/762
(100 %)
1 diff
(99.9 %id)
AA084463 pineal gland .j-u 933 to 1259 16 to 348       333/348
(95 %)
7 diff
(98.0 %id)
N41973 melanocyte .j-u 957 to 1279 1 to 322   fully sequenced,   322/322
(100 %)
1 diff
(99.7 %id)
TI_149275665   .j-u 980 to 1688 792 to 86   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 707/971
(72 %)
5 diff
(99.5 %id)
BG978887 colon_normal .j-u 985 to 1300 12 to 326       315/329
(95 %)
5 diff
(98.5 %id)
BU676729 lung, Primary Lung Epithelial Cells .j-u 1006 to 1688 696 to 15   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 682/682
(100 %)
2 diff
(99.8 %id)
BQ017673 Chondrosarcoma, Left Pubic Bone .j-u 1009 to 1691 699 to 16   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 684/684
(100 %)
1 diff
(99.9 %id)
AW205892   .j-u 1016 to 1599 601 to 18   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 584/584
(100 %)
2 diff
(99.7 %id)
FN163299 breast carcinoma .j-u 1020 to 1116 97 to 1     Submitted on the opposite strand 97/97
(100 %)
1 diff
(99.0 %id)
AA290797 ovarian tumor, ovary .j-u 1027 to 1383 1 to 358       358/358
(100 %)
1 diff
(99.8 %id)
AL691758   .j-u 1089 to 1650 562 to 1       562/562
(100 %)
0 diff
(100 %id)
AW615189 Kidney .j-u 1132 to 1606 1 to 476     Submitted on the opposite strand 476/476
(100 %)
1 diff
(99.8 %id)
AI433416 Kidney .j-u 1161 to 1629 1 to 469     Submitted on the opposite strand 469/469
(100 %)
5 diff
(99.0 %id)
AI338673 lung .j-u 1176 to 1692 517 to 1       517/517
(100 %)
0 diff
(100 %id)
AI693897 carcinoid, lung .j-u 1176 to 1690 515 to 1       515/515
(100 %)
4 diff
(99.3 %id)
AW271519 Kidney .j-u 1179 to 1691 526 to 14   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 513/513
(100 %)
0 diff
(100 %id)
AI810132 pooled .j-u 1180 to 1687 509 to 2       508/509
(99 %)
0 diff
(100 %id)
AW168746 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .j-u 1180 to 1684 505 to 1       505/505
(100 %)
0 diff
(100 %id)
AI126277   .j-u 1193 to 1692 502 to 3       500/502
(99 %)
0 diff
(100 %id)
AW183977 pooled .j-u 1196 to 1692 499 to 3       497/499
(99 %)
0 diff
(100 %id)
AI332730 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .j-u 1206 to 1692 491 to 6       486/491
(98 %)
0 diff
(100 %id)
AA609171   .j-u 1222 to 1692 473 to 3       471/473
(99 %)
0 diff
(100 %id)
AI801082 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .j-u 1222 to 1691 470 to 1       470/470
(100 %)
0 diff
(100 %id)
AI275470 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .j-u 1224 to 1692 469 to 1       469/469
(100 %)
0 diff
(100 %id)
AW779254 pooled .j-u 1236 to 1687 460 to 1       460/460
(100 %)
9 diff
(98.1 %id)
AW873481 pooled .j-u 1245 to 1692 450 to 3       448/450
(99 %)
0 diff
(100 %id)
AW515850 lymph node, lymphoma, follicular mixed small and largecell .j-u 1246 to 1697 455 to 4       452/455
(99 %)
0 diff
(100 %id)
N33256 melanocyte .j-u 1249 to 1688 439 to 1   fully sequenced,   439/439
(100 %)
2 diff
(99.6 %id)
AI082040 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .j-u 1251 to 1692 447 to 6       442/447
(98 %)
0 diff
(100 %id)
AA725714   .j-u 1252 to 1692 443 to 3       441/443
(99 %)
0 diff
(100 %id)
AI123654 pooled .j-u 1262 to 1688 437 to 11   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 427/438
(97 %)
2 diff
(99.6 %id)
AW302562 brain, three pooled meningiomas .j-u 1262 to 1695 434 to 1       434/434
(100 %)
0 diff
(100 %id)
AA868849   .j-u 1265 to 1781 517 to 1       517/517
(100 %)
0 diff
(100 %id)
AI143642 heart .j-u 1274 to 1697 425 to 2       424/425
(99 %)
0 diff
(100 %id)
AI439363 lymph node, lymphoma, follicular mixed small and largecell .j-u 1274 to 1696 423 to 1       423/423
(100 %)
0 diff
(100 %id)
AA921899 pooled .j-u 1275 to 1777 503 to 1       503/503
(100 %)
1 diff
(99.9 %id)
CN314794 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .j-u 1281 to 1692 12 to 423       412/425
(96 %)
1 diff
(99.8 %id)
AI978704 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .j-u 1303 to 1697 424 to 29       396/424
(93 %)
15 diff
(96.5 %id)
AI806769 pooled .j-u 1305 to 1692 390 to 3       388/390
(99 %)
0 diff
(100 %id)
BG434998 placenta .j-u 1313 to 1691 1 to 379   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 379/379
(100 %)
0 diff
(100 %id)
BM150799 leukopheresis .j-u 1314 to 1783 479 to 11       469/479
(97 %)
0 diff
(100 %id)
AL703534 human skeletal muscle .j-u 1315 to 1755 441 to 1       441/441
(100 %)
0 diff
(100 %id)
AW192423 adenocarcinoma, Pancreas .j-u 1317 to 1697 388 to 8       381/388
(98 %)
0 diff
(100 %id)
AI082803 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .j-u 1324 to 1695 384 to 13   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 372/372
(100 %)
0 diff
(100 %id)
AI375986   .j-u 1328 to 1692 368 to 4       365/368
(99 %)
0 diff
(100 %id)
AI923446 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .j-u 1328 to 1697 433 to 64       370/437
(84 %)
0 diff
(100 %id)
AA904589 pooled .j-u 1330 to 1778 460 to 12   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 449/449
(100 %)
0 diff
(100 %id)
AW058299 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .j-u 1330 to 1697 384 to 17       368/384
(95 %)
0 diff
(100 %id)
AW086461 ovary, papillary serous carcinoma .j-u 1332 to 1778 462 to 16   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 447/447
(100 %)
0 diff
(100 %id)
CK819199 Islets of Langerhans, Pancreas .j-u 1337 to 1684 1 to 348   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 348/348
(100 %)
0 diff
(100 %id)
BM128171 Islets of Langerhans, Pancreas .j-u 1353 to 1691 1 to 339   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 339/342
(99 %)
1 diff
(99.8 %id)
AI933005 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .j-u 1365 to 1783 419 to 1   tiling clone,   419/419
(100 %)
0 diff
(100 %id)
AW472818 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .j-u 1373 to 1691 320 to 1       320/320
(100 %)
1 diff
(99.7 %id)
AI431474 lymph node, lymphoma, follicular mixed small and largecell .j-u 1377 to 1783 408 to 2       407/408
(99 %)
0 diff
(100 %id)
BM717427 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .j-u 1380 to 1691 7 to 314   fully sequenced, AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 308/314
(98 %)
6 diff
(98.1 %id)
CV574810 cornea, eye .j-u 1385 to 1694 1 to 310       310/310
(100 %)
0 diff
(100 %id)
AI214503 carcinoid, lung .j-u 1392 to 1778 387 to 1       387/387
(100 %)
3 diff
(99.3 %id)
AA443271.
matches multiple genes
  .j-u 1398 to 1688 301 to 11   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base), also hits gene BTN3A3andBTN2A1 291/291
(100 %)
2 diff
(99.4 %id)
AA629196 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .j-u 1415 to 1563 149 to 1       149/149
(100 %)
1 diff
(99.4 %id)
DW442851 Liver .j-u 1425 to 1641 17 to 233       217/233
(93 %)
6 diff
(97.5 %id)
N67426 cochlea, ear .j-u 1442 to 1687 247 to 1       247/247
(100 %)
1 diff
(99.6 %id)
GD141120   .j-u 1476 to 1689 1 to 213       213/224
(95 %)
10 diff
(95.6 %id)
AI382704 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .j-u 1481 to 1692 214 to 1       214/214
(100 %)
2 diff
(99.1 %id)
AI811803 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .j-u 1498 to 1696 199 to 1       199/199
(100 %)
0 diff
(100 %id)
BM674787 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .j-u 1535 to 1691 164 to 12   fully sequenced, AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 153/153
(100 %)
0 diff
(100 %id)
AI370542   .j-u 1550 to 1778 230 to 1       230/235
(97 %)
1 diff
(99.6 %id)
AI801794 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .j-u 1579 to 1778 225 to 26   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 200/200
(100 %)
3 diff
(98.5 %id)
AW073384 connective tissue, five pooled sarcomas, including myxoidliposarcoma, solitary fibrous tumor, malignant fibroushistiocytoma, gastrointestinal stromal tumor, andmesothelioma .j-u 1615 to 1778 164 to 1       164/164
(100 %)
0 diff
(100 %id)
BG547395 lung .k-u 1 to 770 1 to 769   tiling clone,   769/769
(100 %)
23 diff
(97.1 %id)
DB054763 testis .l 1 to 570 2 to 571 exact tiling clone, capped   570/570
(100 %)
1 diff
(99.9 %id)
FN098112 breast carcinoma .m-u 1 to 120 1 to 122       122/124
(98 %)
3 diff
(97.6 %id)
FN121007 breast carcinoma .m-u 1 to 121 1 to 121   tiling clone,   121/121
(100 %)
0 diff
(100 %id)
TI_159723979   .m-u 55 to 564 590 to 81 exact AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 510/1036
(49 %)
1 diff
(100.0 %id)
CF887297 Human Lung Epithelial cells, lung .m-u 55 to 564 1 to 510 exact tiling clone, AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 510/510
(100 %)
1 diff
(99.9 %id)
BE925008 amnion_normal .n-u 1 to 322 1 to 318 L4* tiling clone,   318/318
(100 %)
4 diff
(98.8 %id)
AA609585   .o-u 1 to 297 300 to 4 exact tiling clone,   297/300
(99 %)
0 diff
(100 %id)
AV701534 adrenal gland Gene ZFC3H1, variant not shown         Suspected internal deletion, this clone was ignored    
BX103290 pooled Gene ZFC3H1, variant not shown              
AV714021   Gene ZFC3H1, variant not shown         Suspected internal deletion, this clone was ignored    
DW438116 Liver Gene ZFC3H1, variant not shown         This clone was ignored    
EL736982 mixed Gene ZFC3H1, variant not shown         This clone was ignored    
AV688202 hepatocellular carcinoma Gene ZFC3H1, variant not shown         Suspected internal deletion, this clone was ignored    
AV690296 hepatocellular carcinoma Gene ZFC3H1, variant not shown         Suspected internal deletion, this clone was ignored    
AA286810 germinal center B cell Gene ZFC3H1, variant not shown              
AA287745 germinal center B cell Gene ZFC3H1, variant not shown              
AA938869 pooled Gene ZFC3H1, variant not shown              
CA944663 Human Lung Epithelial cells, lung Gene ZFC3H1, variant not shown       AAA Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j-u, .k-u, .l, .m-u, .n-u, .o-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI